Amyotrophic lateral sclerosis
From WikiAnesthesia
Revision as of 20:01, 15 July 2021 by Nirav Kamdar (talk | contribs) (Started page and placed some epidemology facts.)
Amyotrophic lateral sclerosis
| Other names | ALS |
|---|---|
| Anesthetic relevance |
Low |
| Anesthetic management |
- No specific anesthetic drugs are best for this disease - Succinylcholine may cause hyperkalemia due to LMN disease - Non-depolarizing NMDs may be prolonged - Bulbar involvement may increase aspiration risk |
| Specialty |
Neurology |
| Signs and symptoms | |
| Diagnosis |
Based upon clinical signs and symptoms |
| Treatment | |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Provide a brief summary of this comorbidity here.
Anesthetic implications
Preoperative optimization
Intraoperative management
- No ideal anesthesia for this condition
- Take caution with succinylcholine administration as the LMN disease may incite hyperkalemia after administration
- Non-depolarizing neuromuscular blockers may be prolonged
- Take caution with regional anesthesia, although it is not contraindicated
Postoperative management
Related surgical procedures
Pathophysiology
- Progressive upper and lower motor neuron degeneration
Signs and symptoms
- Skeletal muscle weakness
- Atrophy of thenar eminences
Diagnosis
Treatment
Medication
Surgery
Prognosis
Epidemiology
Affects men between the ages of 40-60
References
Top contributors: Nirav Kamdar and Olivia Sutton